
S-Adenosyl-L-methionine disulfate tosylate NEW
Price | $32 | $43 | $66 |
Package | 25mg | 50mg | 100mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-05-27 |
Product Details
Product Name: S-Adenosyl-L-methionine disulfate tosylate | CAS No.: 97540-22-2 |
Purity: 98.61% | Supply Ability: 10g |
Release date: 2025/05/27 |
Product Introduction
Bioactivity
Name | S-Adenosyl-L-methionine disulfate tosylate |
Description | S-Adenosyl-L-methionine disulfate tosylate (Ademetionine disulfate tosylate) is the disulfate-tosylate mixed salt comprising diastereoisomers of ademetionine ions. Ademetionine exhibits anti-inflammatory properties and has been utilized in the treatment of chronic liver disease. |
In vivo | Continuous oral administration of ademetionine for 7 days may induce the activities of CYP450 isoforms CYP1A2 of rats, while it may inhibit the activities of CYP2D6, CYP3A4, CYP2C19 and CYP2C9[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : 72 mg/mL (93.9 mM), Sonication is recommended. DMSO : 60 mg/mL (78.25 mM), Sonication is recommended. |
Keywords | S-Adenosyl-L-methionine disulfate Tosylate | SAdenosylLmethionine disulfate tosylate | S-Adenosyl methionine disulfate | S Adenosyl L methionine disulfate tosylate | RNASynthesis | RNA Synthesis | Inhibitor | inhibit | DNASynthesis | DNA Synthesis | APE1(Ref-1) | AdoMet disulfate | Ademetionine disulfate Tosylate | Ademetionine disulfate |
Inhibitors Related | 5-Fluorouracil | Procaine | Rifaximin | Ribavirin | Guanidine hydrochloride | Methotrexate disodium | N-Nitrosodiethylamine | Cytarabine | Acyclovir | Thymidine | Temozolomide | Folic acid |
Related Compound Libraries | Anti-Tumor Natural Product Library | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Natural Product Library | Natural Product Library for HTS | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-06-06 | |
$0.00/25kg |
VIP2Y
|
Anhuyan (Hainan) Biotechnology Co., LTD
|
2025-06-06 | |
$0.00/1KG |
VIP5Y
|
WeiTai BioPharmaceutical Co.,Ltd(Hangzhou?)
|
2025-05-09 | |
$/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
$0.00/1kg |
VIP5Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2025-04-27 | |
$82.00/25kg |
VIP5Y
|
Shandong Luning Pharmaceutical Co., Ltd.
|
2025-02-22 | |
$0.00/10gram |
VIP3Y
|
Wuhan Senwayer Century Chemical Co.,Ltd
|
2024-12-05 | |
$0.00/1Kg |
VIP1Y
|
Xinxiang Aurora Biotechnology Co.,Ltd.
|
2024-11-13 | |
$1.00/25KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-11 | |
$9.00/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY